New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

A new male birth control pill has passed early safety trials, showing promise with minimal side effects. Larger human trials ...

Patients on Itovebi plus Ibrance and fulvestrant had improved progression-free and overall survival compared to Ibrance-fulvestrant alone.

I had a complete hysterectomy in my late 40s due to endometriosis. I am now 68 and have been on 0.1-mg patches of estradiol ...